Actively Recruiting
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Led by Sun Yat-sen University · Updated on 2025-01-30
10000
Participants Needed
2
Research Sites
1513 weeks
Total Duration
On this page
Sponsors
S
Sun Yat-sen University
Lead Sponsor
F
First People's Hospital of Foshan
Collaborating Sponsor
AI-Summary
What this Trial Is About
This retrospective case-control study aims to investigate the genetic mechanisms of primary Pulmonary Lymphoepithelioma-like Carcinoma, identify genetic susceptibility loci associated with its onset, and explore potential pathogenic genes, providing new insights for its etiological research.
CONDITIONS
Official Title
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologically diagnosed with primary pulmonary lymphoepithelioma-like carcinoma (case group)
- In good physical condition with stable consciousness (control group)
You will not qualify if you...
- Diagnosed with metastatic nasopharyngeal carcinoma (case group)
- Having serious cardiovascular, liver, or kidney disease (case and control groups)
- Having prevalent cancer (control group)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Foshan First People's Hospital
Foshan, Guangdong, China, 528000
Actively Recruiting
2
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
Actively Recruiting
Research Team
W
Wei-Hua Jia, MD
CONTACT
T
Tong-Min Wang, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here